Xinhua Silk Road - Belt and Road Portal, China's silk road economic belt and 21st Century Maritime Silk Road Website Xinhua Silk Road - Belt and Road Portal, China's silk road economic belt and 21st Century Maritime Silk Road Website
Subscribe CustomBlackClose

Belt & Road Weekly Subscription Form

download_pop

Research ReportCustomBlackClose

The full edition of the report is available at Xinhua Silk Road Database. You can click the “Table of Content” to have a general understanding of it.

Click on the button below to create your account and get immediate access to thousands of articles.

Start a Free Trial

Xinhua Silk Road Database
Info

Third party regulation introduced to improve TCM quality

May 24, 2017


Abstract :  An online regulation platform for traditional Chinese medicine (TCM) has opened in Anguo city, Hebei Province, the biggest TCM market in north China. 

TIANJIN, May 24 (Xinhua) -- An online regulation platform for traditional Chinese medicine (TCM) has opened in Anguo city, Hebei Province, the biggest TCM market in north China.

The platform, including third party approval of all medicine on the platform and transparent information on all drug producers, is sponsored by Tasly Holding Group, a pharmaceutical company in the nearby port city of Tianjin.

"TCM production has been industrialized, but illegal production and adulteration still damage the market," said Wang Guihua, secretary-general of China Association of Traditional Chinese Medicine.

Sold by weight and mostly processed from plants and animals parts, TCM ingredients are often altered by dubious means such as soaking them in salt water to increase their weight and mixing them with cheap but similar materials.

Most TCM products lack an acknowledged quality control standards, making foreign pharmaceutical companies and customers wary of the quality of products. Wang believes this to be the biggest obstacle to the full internationalization of the industry.

"It's about time to introduce a trustworthy quality regulation system to supervise every step of the production process," said Yan Xijun, CEO of Tasly Holding Group.

The new platform can guarantee access to information on over 60 major production bases. All the drugs posted on the platform have been tested by a third party organization, to ensure their safety, Yan said.

Traditional Chinese medicine is rarely a prescription medication in European and U.S. markets, but sold as food additives or health care products. However, meeting international standards has become more feasible in recent years.

Since 2010, more traditional Chinese medicine has completed the Food and Drug Administration (FDA)'s clinical trails to prepare for the U.S. Market, including the Kanglaite (KLT), an anti-cancer drug with independent intellectual property rights.

"Our efforts are paying off. Our traceability system means our foreign customers can rest assured that our products are standardized," said Yan.

Scan the QR code and push it to your mobile phone

Keyword: Tasly

Reading:

Tasly remains China's 2019 National Tech Innovation Demonstration Enterprise

Business Brief

Tasly invests in Mesoblast, introduces two stem cell products

Write to Us belt & road login close

Do you want to be a contributor to Xinhua Silk Road and tell us your Belt & Road story? Send your articles to [email protected] and share your stories with more people.

Click on the button below to create your account and get im http://img.silkroad.news.cn/templates/silkroad/en2017te access to thousands of articles.

Start a Free Trial

Ask Us A Question belt & road login close

If you have any questions, please enter them in the box below.

Identifying code Reload

Write to Us belt & road login close

Do you want to be a contributor to Xinhua Silk Road and tell us your Belt & Road story? Send your articles to silkroadweekly@xinhua.org and share your stories with more people.

Click on the button below to create your account and get im http://img.silkroad.news.cn/templates/silkroad/en2017te access to thousands of articles.

Start a Free Trial